Skip to content

Insider · CIK 0002075401

Laura Lee Sandler

cooofficer

Files at ORKA (Oruka Therapeutics, Inc.). First filing Sep 1, 2026, latest Sep 15, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $546k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ORKA: Oruka Therapeutics, Inc.

ORKAOct 9, 2026 · close 82.11

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
44Moderate
ORKAsell 5
Oruka Therapeutics, Inc.
$87k
906 shares
-0%-
17Weak
ORKAsell 510b5-1
Oruka Therapeutics, Inc.
$459k
5,000 shares
-2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 15, 2026ORKA
Oruka Therapeutics, Inc.
SOpen-market sale
Common Stock
-906$95.71$87k235,47827 d ago
Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+5,000$7.80$39k241,38441 d ago
Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-1,000$91.05$91k240,38441 d ago
Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-4,000$92.01$368k236,38441 d ago
Sep 1, 2026ORKA
Oruka Therapeutics, Inc.
MOption exercise
Employee Warrant (right to buy)derivative10b5-1
-5,000$0.00$074,99641 d ago

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Laura Lee Sandler: insider trades and track record | InsiderTell